@article{article, title  = {{OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate}},

 publisher = {{Wiley}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/211397 }},

 year = {{2024}},

 month = {{4}},

 author = {{Brown AD and Fisher L and Curtis HJ and Wiedemann M and Hulme WJ and Speed V and Hopcroft LEM and Cunningham C and Costello RE and Galloway JB and Russell MD et al}},

 doi = {{10.1111/bcp.16062}},

 journal = {{British Journal of Clinical Pharmacology}},

 note = {{Accessed on 2024/12/28}}}